Clinical trial
Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes
NCT00110370
Study timeline
Study start (unknown)2004-04-01Date precision: month
Registry last updated2007-11-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
HoustonTexas, United States1DallasTexas, United States1San AntonioTexas, United States1BirminghamAlabama, United States1PortlandOregon, United States1PhoenixArizona, United States1OmahaNebraska, United States1Salt Lake CityUtah, United States1La JollaCalifornia, United States1MemphisTennessee, United States1LexingtonKentucky, United States1OrangeCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00110370 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.